Two-position three-way Switch Valve Pedal Threaded G1/4 Control Pressure Foot Other Valves & Manifolds


  1. Home
  2. Two-position three-way Switch Valve Pedal Threaded G1/4 Control Pressure Foot
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
Two-position three-way Foot Pressure Control G1/4 Threaded Pedal Valve Switch
Condition: New: A brand-new, unused, unopened, undamaged item in its original packaging (where packaging is Brand:

FEISI

Warranty: 3 Years MPN:

Does not apply

Product Name: Foot valve Country/Region of Manufacture: China
Working Temperature: -5~60°C Length: 12.4cm/4.88 inch
Item Type: FV320 UPC:

Does not apply

Port Size: G1/4" EAN:

Does not apply

Work Pressure: 0~0.8Mpa Material: Metal
Action: direct motion Model:

3 way 2 Position

Media: Air
published on tue nov 09 2021

Two-position three-way Switch Valve Pedal Threaded G1/4 Control Pressure Foot Other Valves & Manifolds

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

Two-position three-way Switch Valve Pedal Threaded G1/4 Control Pressure Foot Other Valves & Manifolds

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS